Table 2. Fight information in patients with inflammatory bowel disease (N = 94).
| Variables | Total (N = 94) | Remission (N = 79) | Flare-up (N = 15) | p value |
|---|---|---|---|---|
| Flight time (hours) | 12.0 (5.5–24.0) | 12.0 (8.0–24.0) | 16.0 (4.0–28.0) | 0.799 |
| Altitude above sea level (m) | 19.0 (6.0–66.3) | 19.0 (6.0–70.0) | 23.0 (6.0–65.0) | 0.885 |
| Number of country | 1.0 (1.0–1.0) | 1.0 (1.0–1.0) | 1.0 (1.0–1.0) | 0.093 |
| Number of city | 1.0 (1.0–1.0) | 1.0 (1.0–2.0) | 1.0 (1.0–1.0) | 0.083 |
| Travel duration (days) | 8.0 (4.0–13.3) | 8.0 (4.0–14.0) | 9.0 (4.0–10.0) | 0.864 |
| Visit of country with high risk traveler’s diarrhea | 45 (47.9%) | 38 (48.1%) | 7 (46.7%) | 1.000 |
| Objective for visit | 0.109 | |||
| Leisure | 72 (76.6%) | 63 (79.7%) | 9 (60.0%) | |
| Bussiness | 22 (23.4%) | 16 (20.3%) | 6 (40.0%) | |
| Pre-travel medical consulting | 66 (70.2%) | 57 (72.2%) | 9 (60.0%) | 0.367 |
| Previous additional prescription | 26 (27.7%) | 19 (24.1%) | 7 (46.7%) | 0.073 |
Variables are expressed as median (IQR) or n (%).
*p value for comparing remission and flare-up groups.